$400,000
$6m post-money valuation cap
Pre-revenue with first client contract valued at $200k
This is a closed fundraise between Fundie Climate Angels and Madica VC (term sheet signed) who has already invested $200k. Fundie Climate Angels will be matching with $200k.
◎ Company overview
Pioneering cultivated meat via a modular bio-manufacturing platform
Newform Foods (formerly Mzansi Meat) is a UK and South African foodtech startup offering a bio-production platform for cultivated animal products. Their technology enables food companies to manufacture cultivated meat (first vertical). Future verticals include: fat, connective tissue, functional ingredients like Omega 3.
Newform provides an end-to-end solution for the cultivated meat value chain - from cell lines to pilot production. Their goal is to accelerate the adoption of cultivated meat globally by lowering barriers to entry. Newform's modular, subscription-based platform reduces risk, cost and timelines for food businesses looking to integrate sustainability.
Since 2020, Newform has made significant advances in refining and testing its flexible bio-manufacturing prototypes focused on scalability and automation. They provide customized packages for food industry clients tailored to specific needs across research, small-volume prototypes, pilot facilities, and licensing agreements.
Problem
The traditional industrial animal agriculture system faces pressing challenges around environmental damage, climate impact, ethics and meeting rising future demand. However, existing cultivated meat solutions have extensive infrastructure requirements, multi-year timelines and uncertainty in navigating emerging regulations.
Newform provides an alternative path into cell-cultured meat production through its modular off-the-shelf bio-platform. Companies can tap into a ready launchpad avoiding the capital intensity and technical complexity facing early movers in cultivated meat:
- Cuts facility setup costs by 90% compared to owning end-to-end infrastructure
- Produce first prototypes in weeks compared to years with alternative solutions
- Sidesteps regulatory delays by only requiring internal tasting approvals to start
- Enables food brands to respond quickly to shifting consumer behaviour
This accelerated process de-risks the route into this emerging space. Newform Food bridges the gap between interest and adoption at a pivotal moment when early adopters are exploring more sustainable meat solutions.
Solution
Newform Foods offers a modular bio-manufacturing platform. This enables food companies to pilot and scale cultivated meat production in-house without intensive upfront investment into full end-to-end infrastructure.
The modular bio-platform provides clients the flexibility to match precise business needs. Newform's range of packages allows food brands to explore use cases spanning research, prototyping, pilot production, and licensing the complete bioprocess 10x cheaper and 3x faster than other players
- Research Module: Cell line development, bioreactor optimization
- Prototype Module: Small-batch manufactured prototypes (60 meatballs)
- Pilot Module: Mid-scale cultivated meat production (556 kg per month)
- Licensing: Full IP transfer of SOPs for in-house bio-manufacturing
This tiered suite of bio-solutions integrates seamlessly under a single umbrella. Newform charts an accessible route into the cultivated meat ecosystem catering to clients at any stage of maturity.
💪🏽Achievements
- Market potential: The global cultivated meat market is expected to reach $25 billion by 2030. Cultivated meat is expected to be 35% of global meat consumption by 2040 and have a CAGR of 41% which presents a large market opportunity. Newform provides a differentiated route to tap into global booming protein demand
- Favorable regulatory environment: Flexible policies in South Africa allow public tastings accelerating product development. This provides a gateway to access European markets pending approval
- Modular bio-manufacturing platform : End-to-end modular solution from cell lines to pilot facilities allows a matching with clients growth & budget. The compact bioreactors enhance efficiency 2-3x and 10 x lower cost point over standard systems.
- ◎ Company overview
- 🚀 Current traction
- 🖥 Technology & Product
- 💸 Investment Opportunity
- 📊 Financial Overview
- 🧾 Sales Plan
- 🌍 Market size
- 🧲 Team
- 🌍 Competition
🚀 Current traction
Revenue
- Pre-revenue, a pipeline of 40+ leads with 5 qualified leads in the pipeline
- Provided cultivated meat prototype to European startup, generated $30K revenue
- Advanced conversations, with Letters of intent being drafted from food manufacturers
Product & Platform
- Established biobank with cell lines from beef, pork and lamb
- Achieved first muscle tissue prototypes from beef and lamb
- Operational bench-scale facility with 100L bioreactor capacity
- Advanced progress on lowering media costs from $113/liter to $40/liter and are making significant strides to move to $0.1/liter
Funding
- Raised $1.04M to date from angel investors and VC funds including Sustainable Food Ventures, Privithi Ventures and Animoca Brands
- Secured $200k bridge funding from Madica VC and follow-on support from previous round investor.
Team
- Founder-led team combines expertise in bioprocessing, cell biology and business strategy
- Beefed up commercialization experience hiring Martin Dovey, seasoned professional from food industry
- Added James Durrant, CEO of UK's Mustard Food and TheSouthAfrican.com, as advisor to support global expansion
Media
🖥 Technology & Product
The Bio-manufacturing Platform
Newform’s patented bio-manufacturing technology centers around a compact bioreactor system optimised for automated mass production of slaughter-free meat and other animal products. Proprietary enhancements 2x cell density yields and progressing on 3x growth rates compared to standard cell cultivation set-ups leading to greater efficiency.
This modular architecture underpins the adaptability of the bio-platform . The standardized process controls and automation additionally minimize contamination risks while enhancing repeatability.
Platform integrates breakthroughs across cell line development, media development and bioreactor design, and bioprinting to overcome major technical hurdles facing lab-grown meat production.
The expanding IP portfolio focuses on scaling output volumes while lowering production costs below conventional meat.
Newform’s bioreactors also run as stand-alone modular units which can flexibly stack together into an integrated pilot facility. There are 4 main product applications:
Pilot | Mid-scale cultivated meat production at clients premises | 10,000L with monthly output of 8342kg/month (Cost/kg = $0.09) | Meat producers selling cultivated meat on small scale (sub 10,000 kg/month) |
Product application | Description | Capacity/Yield | Client use case |
Cell line development | Development a proprietary cell line with a Level of exclusivity for client, bioreactor optimization | N/A | R&D activity to further develop cultivated animal product from cell line |
Prototype | Small-batch manufactured prototypes (60 person tasting) | 100L bench-scale producing small-batches as required | Assess market adoption of cultivated meat |
Scale | Full IP transfer of SOPs for in-house bio-manufacturing. In-house infrastructure | 100,000L with monthly output of 83,420kg/month (Cost/kg = $0.09) | Food Retailers selling meat products, 75,000kg+ per month |
The Production Line
Newform Foods' cultivated meat production line:
- Starts with a biopsy from a donor animal to extract cells
- These cells are then grown up into stocks for use in the bioreactors
- The cells grow in suspension within bioreactors and are fed proprietary media formulations. As the cell density increases, the bioreactors are scaled up sequentially into multiple vessels of 1,000L at commercial scale (up to 10,000L)
- The nutrient-rich broth containing the cultivated biomass is then centrifuged to concentrate it before the remaining moisture is mechanically pressed out.
- The cultivated mass is combined with plant-based materials to form a final hybrid meat product ready for use
In-house demo prototype
Part of this funding round is to build a 1000 L demo prototype to be used for client engagement and in-house production and testing. It will generate over 550 kg of cultivated biomass per month. The media cost at this stage will be $50/liter
💸 Investment Opportunity
Investment trends
The cultivated meat sector has seen surging growth trends, with over $3 billion invested globally across startups in the space as of 2022. Corporate participation is likewise expanding with leading meat processing giants like JBS and Cargill actively acquiring startups to tap into this domain early as a hedge.
Recent deals include:
- Cell-cultured fat startup Cubiq Foods raised €2.5M from Lever VC, Blue Horizon Ventures and other VCs
- Cultivated seafood company Bluu Biosciences secured €8M from Ahren, Lever VC, and other climate VCs
- Novel vegan protein designer Change Foods received $27M from global protein producers ADM and Bunge
Venture enthusiasm mirrors massive enterprise participation as companies urgently seek ways to respond to escalating consumer demands for more ethically, sustainably-produced proteins globally. This enormous latent demand-side opportunity suggests cultivated alternatives will transform into multi-billion dollar categories over the coming decades.
Recent M&A activity demonstrates corporate eagerness to gain strategic exposure early:
- Industry pioneer Memphis Meats was acquired by Major Foods Group in 2021 at a reported valuation exceeding $1 billion
- Brazilian multinational JBS purchased Spanish cultured meat firm BioTech Foods consolidating over 50 related patents
This surging investment momentum highlights the potential for Newform Foods to pave inroads offering modular and affordable bio-manufacturing gateways to expedite sustainable protein’s real-world proliferation. Their differentiated approach sits squarely at the nexus of technological proficiency and commercial viability required to make this critical evolution unfold at scale.
Next possible round: Q3 2024 ($5m)
📊 Financial Overview
New Form Food has 5 main revenue lines:
Scale (100,000L) | $63.3m | $57.6m | 18 months |
Tasting Safari | $15,000 | 7 days | |
Price | COGS | Timeline | |
Prototype: Existing Cell-Line | $150,000 | $60,000 | |
Cell-line Development | $150,000 | $60,000 | 6-12 months |
Pilot (10,000L) | $5.95m | $5.4m | 6-12 months |
Historical finances 2020 - 2023 (4 years)
G&A | $319,856 |
Marketing | $147,531 |
R&D | $208,808 |
Stipend/Salaries | $481,598 |
Total | $1,157,792 |
🧾 Sales Plan
Customer segmentation
Food & Meat Producer
Food & Meat Producers globally are starting to future proof their business by investing in the technology early. JBS and Cargill have all invested or bought into the cultivated meat industry and there are more companies that can benefit from future proofing by gaining access to the technology early.
Food Retailer
Food retailers ultimately are exploring innovations to stock shelves with what customers want. Many have seen progress on plant-base products but are reluctant to to spend millions of dollars in a new technology upfront
Equipment Manufacturer
More niche category, with some equipment manufacturers that are looking to future proof themselves in the farming industry. Looking to purchase more specialised equipment
Africa GTM
- Start in South Africa to showcase capability given flexible regulations and relationships.
- Expand to Kenya, Nigeria and Egypt replicating food producer partnerships and pilots.
- Sign production partnerships with 5 leading food/meat companies to set up pilot facilities (50-100 metric ton capacity).
- Leverage partnerships for distribution into retail and foodservice channels. Target 10-20% shelf share of meat case.
UK/EU GTM
- Establish R&D and production hub in Netherlands given regulatory environment.
- Partner with 2-3 leading meat companies on pilots and market development.
- Once approved for sale, leverage partnerships for EU-wide distribution and target 5-10% shelf share.
GTM strategy
2024 | 2025 | 2026 | 2027 | |
Geography focus | Focus on South Africa and 3 main African countries (Kenya, Nigeria, Egypt) | EU and UK | Middle East
Dubai has a strong focus on the future of food and are actively incentivising companies to build facilities in the region | APAC
There is quite a lot of white space across the region, particularly in seafood |
Product Line | Use cell line development (Phase I) to secure longer engagements with clients wanting a prototype (Phase II) | Convert cell line development to prototype to pilot clients. | Convert prototype to pilot and pilot to scale clients | Fully commercially active producing from tasting to royalties |
Client focus | 1 Cell line development
Pipeline:
Abagold, Rainbow, Chicken, Spur and WW. Rhodes, Finlar | Cell-line Development: 1 client
Prototype: 2 clients
Pilot: 1 client
Pipeline:
Focus on top 10 meat producers in EU | Cell-line Development: 1 client
Prototype: 3 clients
Pilot: $12M: 2 client
Pipeline:
Africa + EU + ME | Cell-line Development: 0
Prototype: 2 clients
Pilot: 2 client
Scale: 1 client
Pipeline:
Africa + EU + ME + APAC |
Tech evolution | Focus on perfecting the 1000L and developing a proprietary bioproduction platform to validate the technology platform
| Finalise proprietary bioproduction platform
R&D on 10,000L
| Commercially active proprietary bioproduction platform
Operating at scale, royalties on 100k kg
R&D on 100,000L | Supporting customers across the value chain
Innovating on each element to provide differentiated services across cell lines, media and bioprocessing |
Projected Revenue | Cell-line Development Client: $150k (1 clients)
$150k | Cell-line Development: 150K (1 client)
Prototype: $300k (2 clients)
Pilot: $6M (1 client)
$6.45M | Cell-line Development: 150K (1 client)
Prototype: $450k (3 clients)
Pilot: $12M (2 client)
Annual maintenance: $160K
Royalty: $20K
$12.78m | Cell-line Development: 0 (0 client)
Prototype: $300k (2 clients)
Pilot: $12M (2 client)
Scale: $70M (1 client)
Annual maintenance: $500K
Royalty: $40K
$86m |
🌍 Market size
African Market
Africa’s livestock numbers are expected to increase by a much larger absolute number and at a higher rate than Asia’s projected 26% rise from 2012 to 2050 (source). With Nigeria and South Africa as key drivers of growth of intensive animal agriculture.
These figures are made evident by the fact that South Africa has the world’s largest feedlot. The Karan Beef feedlot accounts for 70% of South Africa’s beef exports and 30% of the local market (source).
Food Retailers
- Modern grocery retail in Africa is estimated to be a $400B market dominated by large chains like Shoprite, Pick n Pay, Spar, Woolworths.
- Retailers are looking to stock innovative products to meet shifting consumer demand. Cultivated meat offers a new category.
- Food Lovers Market piloted plant-based meat sections. Opportunity to be early movers with cultivated meat and have a smaller corporate structures to allow for innovation projects to be prioritised.
Food & Meat Producers
- Africa has over 700 million livestock with countries like Nigeria, Sudan, and Ethiopia being major producers.
- Meat production is growing rapidly to meet rising demand. Companies like Karan Beef, Astral Foods, Rainbow Chicken are major players.
- As production scales, these companies will need to innovate and find more sustainable methods. Cultivated meat provides an opportunity.
Overall, both producers and retailers face pressure to innovate and will need new technologies like Newform's to stay competitive in the rapidly evolving African food market. Newform's partnerships and focus on enabling these players provide strong positioning.
Understanding the regulations
UK/EU Market
There is a growth in demand with meat consumption in the EU expected to reach 47.5 million tonnes by 2030, up from 44 million tonnes in 2020. In the UK meat consumption is projected to rise to 2.4 million tonnes by 2025 from 2.2 million currently. The rising income levels and demand for high protein foods driving growth especially in processed and packaged meat.
Trends in technology and innovation are focus on:
- Automation, robotics, and data analytics being adopted across supply chain from farm to processing
- Cultivated meat is seen as critical future technology allowing production with far less resources.
There is growing pressure to reduce environmental impact driving tech like biogas, precision agriculture, and process optimisation. Producers investing in startups and piloting production to prepare for consumer adoption of cultivated meat.
- Meat producers have $50B to $2B in revenue, producing 3M to 250K MT annually
- Retailers generate $120B to $25B in revenue, selling 1.5M to 350K MT meat
- Combined this is a $650B market opportunity where demand is high but need to innovate on sustainability
Food Retailers
List of major retailers based on volume and revenue
Company | Revenue in 2022 (USD) | Meat Production (MT) |
Schwarz Group (Lidl) | $120B | 1.5M |
Carrefour | $100B | 1.2M |
Tesco | $80B | 1M |
Aldi | $60B | 800K |
Edeka Group | $58B | 750K |
Rewe Group | $50B | 650K |
Auchan | $45B | 600K |
Leclerc | $40B | 500K |
Sainsbury's | $35B | 450K |
Morrisons | $25B | 350K |
Food & Meat Producers
JBS, one of the world's largest meat producers, recently made significant strides in the field of cultivated meat. They acquired a Spanish cultivated meat company, Biotech Foods for $100m and are currently collaborating to build one of the largest cultivated meat factories in Brazil. This move demonstrates JBS's proactive approach to adopting innovative and sustainable practices in response to the growing awareness of environmental and ethical concerns related to traditional meat production. This strategic investment positions JBS at the forefront of the evolving food industry, showcasing their commitment to staying ahead in the market.
🧲 Team
Brett Thompson (co-founder & CEO) brings over 15 years of food industry and innovation experience founding numerous high impact ventures and most recently pioneering cultivated meat through Newform Foods. He has led the strategic vision and partnerships enabling its breakthrough bio-manufacturing platform model since 2020. His past ventures solving complex real-world problems demonstrate the ambition and technical dexterity required in fast-growth startups.
COO and co-founder Tasneem Karodia (ex-Bain Consultant) brings over 10 years of professional experience spanning strategy consulting, nonprofit leadership, and cultivated meat operations. Together Brett and Tasneem make a complementary pairing equipped with the technical aptitude, commercial acumen, and protein production industry knowledge imperative for delivering Newform's mission.
Product Design & Business Development
BSc. Chartered Acc & Finance
Innovation Director: Kerry Group
PhD in Organic Chemistry
PHD Microbiology
MSc Genetics
MSc Wine Biotech
MSc Biotechnology (candidate)
Agri Technovation
Msc Chemical Engineering (candidate)
Advanced Diploma in Biotechnology, Applied Science
🌍 Competition
Competitors Landscape
The cultivated meat competitive landscape remains open for disruption across Africa, the UK, and Europe. Small early startups are scattered trying to gain traction, while regulatory policies still present obstacles for rapid testing and adoption in many areas.
However, South Africa uniquely provides flexibility allowing public tastings of cell-cultured prototypes, accelerating real-world evaluations. This positions local players like Newform Foods to lead development gaining a 12-18 month head start perfecting products matched to consumer preferences through extensive trials. Interest in the African market likewise remains less saturated compared to Europe currently.
In contrast, countries across the EU face more ambiguity still working to formalize oversight policies for both R&D as well as ultimate sale of finished products. Strict Novel Foods acts stipulate extensive safety reviews often taking years before authorizing first meat alternative introductions in these markets.
Newform Foods strategically leverages South Africa's supportive cultivated meat backdrop to accelerate prototyping while linking with partners in innovation-friendly UK regions.
USA
United States Department of Agriculture (USDA) approved the first-ever lab-grown meat for 2 companies:
- UPSIDE Foods will be cultivating and selling chicken that is produced in labs using bioreactors.
- Good Meat, the cultivated meat division of Eat Just, a food technology company providing plant-based egg substitutes.
EU
Meatable (🇳🇱), received funding of USD 35 million that it will use for the production of lab-grown sausages, pork products, and dumplings.
Company | Country | Summary | Technology Level | Investment raised |
Mosa Meat | 🇳🇱 Netherlands | Developed world's first cultured burger; focusing on scaling and cost reductions to enable market launch | Advanced pilot production | $96M over 7 rounds, latest $55M Series B to fund facility and production line expansion |
Meatable | 🇳🇱 Netherlands | Using self-assembling muscle and fat to produce slaughter-free meat; aiming for 2024 market entry | Seed funding supported continued R&D | $35M in latest round, $95M total to prep manufacturing by 2024 |
Higher Steaks | 🇬🇧 UK | Cultivating pork products like bacon and pork belly using harmless harvested stem cells | Early R&D stage | €18.2K funding secured for ongoing research |
Biotech Foods | 🇪🇸 Spain | Leading Meat4All consortium to increase production tech for affordable cultivated meat in EU | Piloting technologies under EU grant funding | €2.7M EU Horizon 2020 Acquired by JBS for $100m |
WildBio | 🇿🇦 South Africa | Rebranded Mogale Meat focusing on meat from African livestock breeds to support food security | Early R&D stage | Seed funding to enable market testing and consumer research |
Bluu Biosciences | 🇩🇪 Germany | Focused on fish fillets using cell lines from various marine species | Early R&D stage | Recently closed €5M seed round to fund product development |
Umami Bioworks | 🇸🇬 Singapore | A scalable and automated solution for seafood producers to produce high-quality, cultivated seafood | Early R&D stage | Raised $2.57M over 8 rounds |
Extracellular | 🇬🇧 UK | CDMO (contract development and manufacturing organisation) dedicated to supporting sustainable biotechnology | Early R&D stage - scaling up technology being advanced | Recent funding includes more than $1.2M USD in advanced subscriptions, In addition, Extracellular has secured $700K in non-dilutive funding |
Disclaimer: This memo and all documents presented and attached here is confidential and intended for Fundie Ventures and its affiliates. It is strictly forbidden to share any part of this document with any third party, without a written consent.
See all deals:
Fundie Venture Deals